The People
Medicare Patients Become Eligible for GLP-1 Weight-Loss Drugs Starting July 1
Starting July 1, Medicare patients can access GLP-1 weight-loss drugs under a new CMS pilot program, broadening coverage for the popular but costly medications. The change marks a significant expansion of obesity treatment for older Americans.
Read Full Story at Washington ExaminerDiscussSoon← Front Page